Sidley Healthcare Investment Conference

Tuesday, September 12

London

Agenda

Tuesday
SEPTEMBER 12
10:30 a.m.

REGISTRATION AND NETWORKING

Registration and Networking Brunch
11:30 a.m.

WELCOME REMARKS AND INTRODUCTION

CONFERENCE WELCOME: Thomas Thesing, Managing Partner, London Office, and Head of London Corporate Group, Sidley (London)
UK LIFE SCIENCES INVESTMENT: Dr. Daniel Mahony, Chairman, The Bio Industry Association and UK Life Sciences Envoy
‍A GLOBAL VIEW: Sharon Flanagan, Partner and Leader of Global Life Sciences Practice, Sidley (San Francisco)
11:50 a.m.

PHARMA AND BIOTECH:
THE POWER OF COLLABORATION

INTRODUCED BY: Marie Manley, Partner and Leader of London Life Sciences Team, Sidley (London)
MODERATOR: Asher Rubin, Partner, Technology and Life Sciences Transactions, Sidley (Baltimore)
SPEAKERS:
Douglas Eby, Chief Executive Officer and Founder, Kyttaro
Shaun Grady, Senior Vice President, Business Development Operations, AstraZeneca
Angus Grant, Executive Vice President, Business Development, Teva
Dr. Chris Sheldon, Senior Vice President, Head of Business Development, GSK
12:35 p.m.

PHARMA INVESTING: INDIVIDUAL STRATEGIES FOR SUCCESS – COMPANY BUILDING, IP-BACKED INVESTING, AND PATIENT CAPITAL

INTRODUCED BY: Josefine Sommer, Partner, Food, Drug and Medical Device, Sidley (Brussels)
MODERATOR: Annalisa Jenkins, BioPharma Thought Leader and Non-Executive Director, Genomics England
SPEAKERS:
Roel Bulthuis, Managing Partner, Syncona
Christopher Li Puma, Director, Fortress IP Fund
Stefan Linn, Managing Partner and CEO, LetterOne Health
Peter Thomas, Senior Principal, IQVIA
1:20 p.m.

NETWORKING LUNCH

2:05 p.m.

FIRESIDE CHAT:
A LIFE WELL-INVENTED

INTRODUCED BY: Michael Rosenblatt, MD, Senior Adviser, Flagship Pioneering, Bain Capital Life Sciences and Ascenta Capital
MODERATOR: Robert Darwin, Partner, Private Equity and Life Sciences, Sidley (London)
GUEST: Dr. Noubar Afeyan, Founder and CEO, Flagship Pioneering and Co-Founder and Chairman, Moderna
2:45 p.m.

‍GETTING TO CLOSING: THE IMPACT OF ENERGISED FDI/ANTITRUST REGIMES ON HEALTHCARE DEAL CERTAINTY

INTRODUCED BY: Anne Robert, Partner, Antitrust/Competition, Sidley (Brussels)
MODERATORS:
Sven De Knop, Partner, Global Arbitration, Trade and Advocacy, Sidley (Brussels)
SPEAKER:
Patrick Harrison, Partner, Antitrust/Competition, Sidley (London)
Noel Watson-Doig, Senior Counsel, Business Development and Corporate, GSK
3:35 p.m.

BREAK AND NETWORKING

3:55 p.m.

PRIVATE EQUITY: STATE OF THE HEALTHCARE DEAL MARKET

INTRODUCED BY: Tony Drabble, Senior Principal, IQVIA
MODERATOR: Chad D. Ehrenkranz, Partner, Healthcare, Sidley (New York)
SPEAKERS:
Luca Bonanomi, Managing Director, Private Equity Group, Blackstone
Edward de Nor, Partner, GHO Capital Partners 
Kasper Gyldenvang, Vice President, Permira
Andre Valente, Partner, L.E.K. Consulting
4:40 p.m.

COMFORT BREAK

4:50 p.m.

FOCUS ON WOMEN'S HEALTH: THE NEW DEAL FRONTIER

INTRODUCED BY: Eve-Anadel Coronado, General Counsel, Advanz Pharma
MODERATOR: Adriana Tibbitts, Partner, Technology and Life Sciences Transactions, Sidley (Baltimore)
SPEAKERS:
Nicole Hijnen, President of the Board, Freya Pharma Solutions
Daniel Karp, Chief Business Development Officer, Organon
Thomas Riisager, Chief Corporate Development Officer, Theramex
5:40 p.m.

FUNDING AND STRATEGIC ALTERNATIVES FOR EMERGING LIFE SCIENCES COMPANIES - VENTURE CAPITAL, IPOs, PUBLIC MARKETS, AND BEYOND

INTRODUCED BY: Raymond Berglund, Managing Director, Life Sciences and CFO Services, Alvarez & Marsal 
MODERATOR: Frank Rahmani, Partner, Sidley (Palo Alto)
SPEAKERS:
Michael Martin, Global Head, Takeda Ventures and Global Head, Center for External Innovation, Takeda Pharmaceuticals
Naveed Siddiqi, Senior Partner, Venture Investments, Novo Holdings
John Whittaker, Managing Director, Citi
6:25 p.m.

CLOSING REMARKS

Robert Darwin, Partner, Private Equity and Life Sciences, Sidley (London)
6:30 p.m.

NETWORKING DRINKS AND CANAPÉS RECEPTION

Speakers

Dr. Noubar Afeyan

Founder and CEO, Flagship Pioneering and Co-Founder and Chairman, Moderna

ModernaView Bio

Raymond Berglund

Managing Director

View Bio

Luca Bonanomi

Managing Director

View Bio

Roel Bulthuis

Managing Partner

View Bio

Eve-Anadel Coronado

Group General Counsel

View Bio

Robert Darwin

Partner, Private Equity
and Life Sciences

Sidley

View Bio

Sven de Knop

Partner, Global Arbitration, Trade and Advocacy

Sidley

View Bio

Edward de Nor

Partner

View Bio

Tony Drabble

Senior Principal

View Bio

Douglas Eby

CEO and Founder

Kyttaro

View Bio

Chad Ehrenkranz

Partner, Healthcare

Sidley

View Bio

Sharon Flanagan

Partner and Leader of Global Life Sciences Practice

Sidley

View Bio

Shaun Grady

Senior Vice President, Business Development Operations

View Bio

Dr. Angus Grant

Executive Vice President, Business Development

View Bio

Kasper Gyldenvang

Healthcare Investor

View Bio

Patrick Harrison

Partner, Antitrust/Competition

Sidley

View Bio

Dr. Nicole Hijnen

President of the Board

View Bio

Dr. Annalisa Jenkins

BioPharma Thought Leader and Non-Executive Director

View Bio

Daniel Karp

Chief Business Development Officer

View Bio

Stefan Linn

Managing Partner and CEO

View Bio

John Christopher LiPuma

Director

View Bio

Dr. Daniel Mahony

Chairman

UK Life Sciences Envoy

View Bio

Marie Manley

Partner and Leader of London Life Sciences Team

Sidley

View Bio

Michael Martin

Global Head, Takeda Ventures and Global Head, Center for External Innovation, Takeda Pharmaceuticals

View Bio

Frank Rahmani

Partner, Emerging Companies and Venture Capital

Sidley

View Bio

Thomas Riisager

Chief Corporate Development Officer

View Bio

Anne Robert

Partner, Antitrust/Competition

Sidley

View Bio

Dr. Michael Rosenblatt

Senior Adviser

View Bio

Asher Rubin

Partner, Technology and Life Sciences Transactions

Sidley

View Bio

Dr. Chris Sheldon

Senior Vice President, Head of Business Development

View Bio

Dr. Naveed Siddiqi

Senior Partner

View Bio

Josefine Sommer

Partner, Food, Drug and Medical Device

Sidley

View Bio

Thomas Thesing

London Managing Partner and Head of London Corporate Group

Sidley

View Bio

Peter Thomas

Senior Principal

View Bio

Adriana Tibbitts

Partner, Technology and Life Sciences Transactions

Sidley

View Bio

Andre Valente

Partner

View Bio

Noel
Watson-Doig

Senior Counsel, Business Development and Corporate

View Bio

John Whittaker

Managing Director

View Bio

Resources

With a Threatened Recession, Life Sciences Companies and Healthcare Providers Consider Alternative Liquidity Options

Alternative Sources of Capital for Biotechs

Anatomy of a CVR: A Primer on the Key Components and Trends of CVRs in Life Sciences Public M&A Deals

Sidley Global Life Sciences LinkedIn Page

Sidley Trendspotting Report 2023 - On the Pulse of Global Life Sciences

Sidley GoodLifeSci Blog

In partnership with:
SIDLEY AUSTIN LLP
PRIVACY POLICY